These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29377000)

  • 1. [New possibilities of treatment of low back pain].
    Kamchatnov PR; Chugunov AV; Khanmurzaeva SB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):162-167. PubMed ID: 29377000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative analysis of the use of symptomatic slow acting drugs for osteoarthritis containing chondroitin sulfate or affecting its biosynthesis in patients with non-specific low back pain].
    Sarvilina IV; Danilov AB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(1):81-96. PubMed ID: 36719123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An antinociceptive effect of chondroprotectors: a myth or a reality?].
    Danilov AB; Grigorenko NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(9):84-89. PubMed ID: 26569010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review of chondroitin sulfate in osteoarthritis.
    Uebelhart D
    Osteoarthritis Cartilage; 2008; 16 Suppl 3():S19-21. PubMed ID: 18674931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathobiology of osteoarthritis and the rationale for using the chondroitin sulfate for its treatment.
    Volpi N
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):119-27. PubMed ID: 15180452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Condrosulf®: structural characterization, pharmacological activities and mechanism of action.
    Volpi N
    Curr Med Chem; 2014; 21(34):3949-61. PubMed ID: 25245376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic slow-acting drugs for osteoarthritis: what are the facts?
    Dougados M
    Joint Bone Spine; 2006 Dec; 73(6):606-9. PubMed ID: 17126058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological treatment of osteoarthritis. Expectations and reality].
    Mulero Mendoza J
    Rev Clin Esp; 2005 Apr; 205(4):168-71. PubMed ID: 15860188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of glucosamine and chondroitin sulfate in the management of osteoarthritis.
    Brief AA; Maurer SG; Di Cesare PE
    J Am Acad Orthop Surg; 2001; 9(2):71-8. PubMed ID: 11281631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondroitin sulphate: a focus on osteoarthritis.
    Bishnoi M; Jain A; Hurkat P; Jain SK
    Glycoconj J; 2016 Oct; 33(5):693-705. PubMed ID: 27194526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical status and treatment options for osteoarthritis in patients with frailty].
    Naumov AV; Khovasova NO; Moroz VI; Tkacheva ON; Shavlovskaya OA
    Ter Arkh; 2019 Dec; 91(12):135-141. PubMed ID: 32598601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucosamine and chondroitin sulfate as a possible treatment for osteoarthritis].
    Bijlsma JW
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1819-23. PubMed ID: 12382365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The possibilities of using chondroitin sulfate in patients with chronic back pain].
    Istomina EV; Shikhkerimov RK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3):12-15. PubMed ID: 31089089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy Treatment of Osteoarthritis with Combine Chondroitin and Glucosamine.
    Materkowski M
    Ortop Traumatol Rehabil; 2021 Jun; 23(3):239-244. PubMed ID: 34190047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiresorptive-cytokine effects of the chondroprotective therapy in patients with lower back pain].
    Zolotovskaya IA; Davydkin IL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(4):65-71. PubMed ID: 32490621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SYSADOA place in degenerative-dystrophic joints diseases treatment of neurological practice from the standpoint of evidence-based medicine].
    Shavlovskaya OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(3):38-45. PubMed ID: 35394718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study.
    Rovati LC; Girolami F; D'Amato M; Giacovelli G
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S34-41. PubMed ID: 26632505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence?
    Hochberg M; Chevalier X; Henrotin Y; Hunter DJ; Uebelhart D
    Curr Med Res Opin; 2013 Mar; 29(3):259-67. PubMed ID: 23186102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of nonspecific lower back pain in patients with high cardiovascular risk].
    Zolotovskaya IA; Davydkin IL; Poverennova IE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(8):18-23. PubMed ID: 31626166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.